Literature DB >> 8577996

Invasion of cultured human cells by Streptococcus pyogenes.

R Greco1, L De Martino, G Donnarumma, M P Conte, L Seganti, P Valenti.   

Abstract

The invasive capacity of streptococcal strains belonging to groups A and B was evaluated by infecting human epithelial and endothelial cells and monitoring the number of viable intracellular bacteria at different times postinfection. All strains tested entered eukaryotic cells (HeLa, HEp2 and HUVE), with Streptococcus pyogenes exhibiting a higher invasion efficiency than group B streptococci (GBS). No intracellular multiplication was observed, and GBS remained viable 24 h postinfection, whereas S. pyogenes were gradually killed. We found that cytochalasin D almost completely inhibited internalization of all bacterial strains, whereas colchicine had no effect, indicating that host microfilaments play a major role in bacterial internalization. Moreover, the use of the lysosomotropic agent ammonium chloride enabled us to demonstrate that a pH increase in the intracellular vesicles did not affect streptococcal entry. These results were documented by electron microscopic observations which revealed the different steps in the invasion pathway, including a fusion event between phagosomes containing S. pyogenes and lysosomes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8577996     DOI: 10.1016/0923-2508(96)80561-4

Source DB:  PubMed          Journal:  Res Microbiol        ISSN: 0923-2508            Impact factor:   3.992


  28 in total

1.  Role of CsrR, hyaluronic acid, and SpeB in the internalization of Streptococcus pyogenes M type 3 strain by epithelial cells.

Authors:  Jeries Jadoun; Osnat Eyal; Shlomo Sela
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

2.  SpyA, a C3-like ADP-ribosyltransferase, contributes to virulence in a mouse subcutaneous model of Streptococcus pyogenes infection.

Authors:  Jessica S Hoff; Mark DeWald; Steve L Moseley; Carleen M Collins; Jovanka M Voyich
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

3.  Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection.

Authors:  H M Schrager; J G Rheinwald; M R Wessels
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

4.  Group A Streptococcus induces apoptosis in human epithelial cells.

Authors:  P J Tsai; Y S Lin; C F Kuo; H Y Lei; J J Wu
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

5.  A globally disseminated M1 subclone of group A streptococci differs from other subclones by 70 kilobases of prophage DNA and capacity for high-frequency intracellular invasion.

Authors:  P P Cleary; D LaPenta; R Vessela; H Lam; D Cue
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

6.  Streptococcus pyogenes M49 plasminogen/plasmin binding facilitates keratinocyte invasion via integrin-integrin-linked kinase (ILK) pathways and protects from macrophage killing.

Authors:  Nikolai Siemens; Nadja Patenge; Juliane Otto; Tomas Fiedler; Bernd Kreikemeyer
Journal:  J Biol Chem       Date:  2011-04-26       Impact factor: 5.157

7.  High-frequency invasion of epithelial cells by Streptococcus pyogenes can be activated by fibrinogen and peptides containing the sequence RGD.

Authors:  D R Cue; P P Cleary
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

8.  Cytolysin-dependent evasion of lysosomal killing.

Authors:  Anders Håkansson; Colette Cywes Bentley; Elizabeth A Shakhnovic; Michael R Wessels
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-28       Impact factor: 11.205

9.  The CsrR/CsrS two-component system of group A Streptococcus responds to environmental Mg2+.

Authors:  Ioannis Gryllos; James C Levin; Michael R Wessels
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-19       Impact factor: 11.205

10.  Invasion of porcine brain microvascular endothelial cells by Streptococcus suis serotype 2.

Authors:  Ghyslaine Vanier; Mariela Segura; Peter Friedl; Sonia Lacouture; Marcelo Gottschalk
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.